Sophie Giesler
Freiburg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Biology-driven therapies of CAR T immune effector cell-associated neurotoxicity syndrome.
Journal: Immunotherapy
Published: May 29, 2025
Two heads are better than one: a synergistic strategy for conquering graft-versus-host disease.
Journal: Haematologica
Published: April 01, 2025
Immune-mediated colitis after immune checkpoint inhibitor therapy.
Journal: Trends in molecular medicine
Published: July 31, 2024
MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production.
Journal: Molecular cancer research : MCR
Published: November 09, 2022
A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab- ozogamicin.
Journal: Leukemia & lymphoma
Published: May 20, 2022
Deciphering the role of Minor histocompatibility antigens for acute graft-versus-host disease.
Journal: Transplantation and cellular therapy
Published: July 02, 2021
Expression of combinatorial immunoglobulins in macrophages in the tumor microenvironment.
Journal: PloS one
Published: November 29, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026